Financhill
Back

bluebird bio 10K Form

Sell
27

BLUE
bluebird bio

Last Price:
0.46
Seasonality Move:
4.77%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BLUE News And Ratings

See the #1 stock for the next 7 days that we like better than BLUE

BLUE Financial Statistics

Sales & Book Value

Annual Sales: $29.5M
Cash Flow: $-66.31M
Price / Cash Flow: 0
Annual Sales: $0.27
Price / Book: 1.7

Profitability

EPS (TTM): -2.22000
Net Income (TTM): $-311.44M
Gross Margin: $-4.03M
Return on Equity: -174.94%
Return on Assets: -50.68%

bluebird bio Earnings Forecast

Key bluebird bio Financial Ratios

  • The Gross Profit Margin over the past 17 years for BLUE is -13.66%.
  • The Selling, General & Administrative Expenses for BLUE have been equal to 561.11% of Gross Profit Margin.
  • The Research & Development expenses have been 568.37% of Revenue.
  • The Interest Expense is -7.72% of Operating Income.
  • The Net Earning history of BLUE is -718.42% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 10 years.

bluebird bio Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BLUE
CUSIP: 09609G
Website: bluebirdbio.com

Debt

Debt-to-Equity Ratio: 1.32
Current Ratio: 0.68
Quick Ratio: 0.54

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BLUE Technical Analysis vs Fundamental Analysis

Sell
27
bluebird bio (BLUE) is a Sell

Is bluebird bio a Buy or a Sell?

  • bluebird bio stock is rated a Sell
    The current bluebird bio [BLUE] share price is $0.46. The Score for BLUE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.